Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis

Background. Myasthenia gravis is a chronic, autoimmune disease with muscle weakness. Acetylcholinesterase inhibitors are used in the symptomatic treatment of the disease. Allergic reaction to pyridostigmine bromide is rare. In the literature, no allergic reaction to pyridostigmine bromide has...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatih Kaplan, Erdem Topal
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2023-04-01
Series:The Turkish Journal of Pediatrics
Subjects:
Online Access:https://turkjpediatr.org/article/view/38
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850042125216907264
author Fatih Kaplan
Erdem Topal
author_facet Fatih Kaplan
Erdem Topal
author_sort Fatih Kaplan
collection DOAJ
description Background. Myasthenia gravis is a chronic, autoimmune disease with muscle weakness. Acetylcholinesterase inhibitors are used in the symptomatic treatment of the disease. Allergic reaction to pyridostigmine bromide is rare. In the literature, no allergic reaction to pyridostigmine bromide has been reported in the pediatric population. Case. A 12-year-old female patient diagnosed with myasthenia gravis consulted our clinic with the complaint of urticaria due to pyridostigmine bromide. The oral challenge test performed with pyridostigmine bromide was positive. As the patient was required to be continue pyridostigmine bromide with no suitable alternatives, it was decided that the patient had to be desensitized to pyridostigmine. During and after the desensitization protocol, no reaction was observed. Conclusions. In this report, a successful desensitization protocol for pyridostigmine bromide in a child with myasthenia gravis is discussed.
format Article
id doaj-art-40a5d11eaab948c598a2d1de3fb5c309
institution DOAJ
issn 0041-4301
2791-6421
language English
publishDate 2023-04-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-40a5d11eaab948c598a2d1de3fb5c3092025-08-20T02:55:38ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212023-04-0165210.24953/turkjped.2022.386Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravisFatih Kaplan0Erdem Topal1Department of Pediatric Allergy and Immunology, İnönü University Faculty of Medicine, Malatya, Türkiye.Department of Pediatric Allergy and Immunology, İnönü University Faculty of Medicine, Malatya, Türkiye. Background. Myasthenia gravis is a chronic, autoimmune disease with muscle weakness. Acetylcholinesterase inhibitors are used in the symptomatic treatment of the disease. Allergic reaction to pyridostigmine bromide is rare. In the literature, no allergic reaction to pyridostigmine bromide has been reported in the pediatric population. Case. A 12-year-old female patient diagnosed with myasthenia gravis consulted our clinic with the complaint of urticaria due to pyridostigmine bromide. The oral challenge test performed with pyridostigmine bromide was positive. As the patient was required to be continue pyridostigmine bromide with no suitable alternatives, it was decided that the patient had to be desensitized to pyridostigmine. During and after the desensitization protocol, no reaction was observed. Conclusions. In this report, a successful desensitization protocol for pyridostigmine bromide in a child with myasthenia gravis is discussed. https://turkjpediatr.org/article/view/38allergydesensitizationmyasthenia gravispyridostigmine bromide
spellingShingle Fatih Kaplan
Erdem Topal
Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis
The Turkish Journal of Pediatrics
allergy
desensitization
myasthenia gravis
pyridostigmine bromide
title Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis
title_full Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis
title_fullStr Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis
title_full_unstemmed Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis
title_short Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis
title_sort successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis
topic allergy
desensitization
myasthenia gravis
pyridostigmine bromide
url https://turkjpediatr.org/article/view/38
work_keys_str_mv AT fatihkaplan successfuldesensitizationprotocolforpyridostigmineina12yearoldpatientwithmyastheniagravis
AT erdemtopal successfuldesensitizationprotocolforpyridostigmineina12yearoldpatientwithmyastheniagravis